These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31965581)

  • 1. Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz.
    Bisso A; Filipuzzi M; Gamarra Figueroa GP; Brumana G; Biagioni F; Doni M; Ceccotti G; Tanaskovic N; Morelli MJ; Pendino V; Chiacchiera F; Pasini D; Olivero D; Campaner S; Sabò A; Amati B
    Hepatology; 2020 Oct; 72(4):1430-1443. PubMed ID: 31965581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC.
    Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS
    Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
    Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
    J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
    Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.
    Zhang Y; Xu H; Cui G; Liang B; Chen X; Ko S; Affo S; Song X; Liao Y; Feng J; Wang P; Wang H; Xu M; Wang J; Pes GM; Ribback S; Zeng Y; Singhi A; Schwabe RF; Monga SP; Evert M; Tang L; Calvisi DF; Chen X
    Gastroenterology; 2022 Aug; 163(2):481-494. PubMed ID: 35489428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosslinked Extracellular Matrix Stiffens Human Trabecular Meshwork Cells Via Dysregulating β-catenin and YAP/TAZ Signaling Pathways.
    Yemanyi F; Vranka J; Raghunathan VK
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):41. PubMed ID: 32832971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Wnt Signaling Activates YAP/TAZ.
    Park HW; Kim YC; Yu B; Moroishi T; Mo JS; Plouffe SW; Meng Z; Lin KC; Yu FX; Alexander CM; Wang CY; Guan KL
    Cell; 2015 Aug; 162(4):780-94. PubMed ID: 26276632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-Catenin Signaling Regulates Yap/Taz Activity during Embryonic Development in Zebrafish.
    Astone M; Tesoriero C; Schiavone M; Facchinello N; Tiso N; Argenton F; Vettori A
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
    Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
    Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
    J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
    Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D
    Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.
    Wang H; Zhang S; Zhang Y; Jia J; Wang J; Liu X; Zhang J; Song X; Ribback S; Cigliano A; Evert M; Liang B; Wu H; Calvisi DF; Zeng Y; Chen X
    J Hepatol; 2022 Jan; 76(1):123-134. PubMed ID: 34464659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.
    Xiong J; Almeida M; O'Brien CA
    Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
    Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
    Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
    Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
    [No Abstract]   [Full Text] [Related]  

  • 18. Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice.
    Srivastava J; Siddiq A; Gredler R; Shen XN; Rajasekaran D; Robertson CL; Subler MA; Windle JJ; Dumur CI; Mukhopadhyay ND; Garcia D; Lai Z; Chen Y; Balaji U; Fisher PB; Sarkar D
    Hepatology; 2015 Mar; 61(3):915-29. PubMed ID: 25065684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.
    Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G
    Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.
    Azzolin L; Panciera T; Soligo S; Enzo E; Bicciato S; Dupont S; Bresolin S; Frasson C; Basso G; Guzzardo V; Fassina A; Cordenonsi M; Piccolo S
    Cell; 2014 Jul; 158(1):157-70. PubMed ID: 24976009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.